US 7501260
Methods for determining efficacy of chemotherapeutic agents for a patient prior to treatment
granted A61PA61P17/02A61P31/00
Quick answer
US patent 7501260 (Methods for determining efficacy of chemotherapeutic agents for a patient prior to treatment) held by Precision Therapeutics, Inc. expires Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Precision Therapeutics, Inc.
- Grant date
- Tue Mar 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 38
- CPC classes
- A61P, A61P17/02, A61P31/00, A61P35/00, A61P37/02